SCHEMBL19895182

SCHEMBL19895182

Cc1ccccc1-c1c(C)sc2cnc(Nc3ccc(C4CCNCC4)cc3OC(C)C)nc12

nearest known ligand 0.87

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 18/20 0.87
▸ INSR P06213 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ EGFR P00533 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18181693 0.93 ALK (1.00) ALKINSRKCNH2EGFR
SCHEMBL19895210 0.89 ALK (0.69) ALKINSRKCNH2EGFR
SCHEMBL18181711 0.88 ALK (1.00) ALKEGFR
SCHEMBL18181728 0.86 ALK (0.88) ALKINSRKCNH2
SCHEMBL19895166 0.84 ALK (0.66) ALKINSR
SCHEMBL18181663 0.83 ALK (0.79) ALKINSRKCNH2EGFR
SCHEMBL15283080 0.81 ALK (0.83) ALK
SCHEMBL18181618 0.80 ALK (1.00) ALKEGFR
SCHEMBL15283503 0.79 ALK (0.87) ALK
SCHEMBL18181619 0.79 ALK (1.00) ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111440189-B Fused ring pyrimidine amino derivative, preparation method, intermediate, pharmaceutical composition and application thereof 广州再极医药科技有限公司 2022-08-09 — — CN disclosed
CN-110078741-B Fused ring pyrimidine amino derivative, preparation method, intermediate, pharmaceutical composition and application thereof 广州再极医药科技有限公司 2021-10-01 — — CN disclosed
CN-106220644-B Fused ring pyrimidine amino derivative, preparation method, intermediate, pharmaceutical composition and application thereof 广州再极医药科技有限公司 2020-07-31 — — CN disclosed
CN-111440189-A Fused ring pyrimidine amino derivative, preparation method, intermediate, pharmaceutical composition and application thereof 广州再极医药科技有限公司 2020-07-24 — — CN disclosed
EP-3287463-A1 CONDENSED-RING PYRIMIDYLAMINO DERIVATIVE, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (CN) 2018-02-28 — — EP disclosed
Send feedback